08.05.2013 07:20 Uhr, Quelle: Wallstreet online

Actelion provides update on Phase III GRIPHON study with selexipag in pulmonary arterial hypertension - Study continues

Actelion Pharmaceuticals Ltd / Actelion provides update on Phase III GRIPHON study with selexipag in pulmonary arterial hypertension - Study continues . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the …

Weiterlesen bei Wallstreet online

Digg del.icio.us Facebook email MySpace Technorati Twitter

JustMac.info © Thomas Lohner - Impressum - Datenschutz